- Events, Presentations and Webcasts
- Repros in the News
- Major Holders
- Analyst Coverage
- SEC Filings
- Corporate Governance
Repros Therapeutics Inc.
$9.30 
0.30 (3.33%)
Nasdaq: RPRX
| Analyst | Bank |
| Brian Abrahams, M.D. | Oppenheimer & Co. Inc. |
| Matthew Kaplan | Punk Ziegel & Company |
| Kimberly Lee, D.O. | Pacific Growth Equities |
| David Martin, Ph.D., MBA | Dundee Securities |